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Myotonic dystrophy (DM), the most common form of muscular dystrophy in adults, can be caused by a mutation
on either chromosome 19 (DM1) or 3 (DM2). In 2001, we demonstrated that DM2 is caused by a CCTG expansion
in intron 1 of the zinc ﬁnger protein 9 (ZNF9) gene. To investigate the ancestral origins of the DM2 expansion, we
compared haplotypes for 71 families with genetically conﬁrmed DM2, using 19 short tandem repeat markers that
we developed that ﬂank the repeat tract. All of the families are white, with the majority of Northern European/
German descent and a single family from Afghanistan. Several conserved haplotypes spanning 1700 kb appear
to converge into a single haplotype near the repeat tract. The common interval that is shared by all families with
DM2 immediately ﬂanks the repeat, extending up to 216 kb telomeric and 119 kb centromeric of the CCTG
expansion. The DM2 repeat tract contains the complex repeat motif (TG)n(TCTG)n(CCTG)n. The CCTG portion
of the repeat tract is interrupted on normal alleles, but, as in other expansion disorders, these interruptions are
lost on affected alleles. We examined haplotypes of 228 control chromosomes and identiﬁed a potential premutation
allele with an uninterrupted (CCTG)20 on a haplotype that was identical to the most common affected haplotype.
Our data suggest that the predominant Northern European ancestry of families with DM2 resulted from a common
founder and that the loss of interruptions within the CCTG portion of the repeat tract may predispose alleles to
further expansion. To gain insight into possible function of the repeat tract, we looked for evolutionary conservation.
The complex repeat motif and ﬂanking sequences within intron 1 are conserved among human, chimpanzee, gorilla,
mouse, and rat, suggesting a conserved biological function.
Introduction
Myotonic dystrophy (DM) is an autosomal dominant,
multisystemic disease with a consistent constellation of
clinical features, including myotonia, muscular dystro-
phy, cardiac-conduction defects, posterior iridescent cat-
aracts, and endocrine disorders (Harper 2001). In 1992,
the mutation for myotonic dystrophy type 1 (DM1
[MIM 160900]) on chromosome 19 was shown to be
caused by an expanded CTG repeat in the 3′ UTR of
the dystrophia myotonica-protein kinase (DMPK) gene
(Brook et al. 1992; Buxton et al. 1992; Fu et al. 1992;
Harley et al. 1992; Mahadevan et al. 1992). In 1998,
we mapped the myotonic dystrophy type 2 (DM2 [MIM
602668]) locus to 3q21 (Ranum et al. 1998), and we
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recently identiﬁed the mutation as a CCTG expansion
in intron 1 of the zinc ﬁnger protein 9 (ZNF9) gene
(Liquori et al. 2001). In Europe, the disease in these
families has been called “proximal myotonic myopathy”
(PROMM [MIM600109]) (Ricker et al. 1994) or “proxi-
mal myotonic dystrophy” (PDM) (Udd et al. 1997), and,
in the United States, these families were initially de-
scribed as “having myotonic dystrophy with no CTG
repeat expansion” (Thornton et al. 1994; Day et al.
1999). Clinical and molecular parallels between DM1
and DM2 indicate that CUG and CCUG microsatellite
expansions in RNA can be pathogenic and can cause
the multisystemic features of both diseases (Day et al.
1999, 2003; Ricker 1999; Liquori et al. 2001; Ranum
and Day 2002).
The DM2 repeat tract is a complex repeat motif with
an overall conﬁguration of (TG)n(TCTG)n(CCTG)n. In
the general population, the DM2 repeat tract is stable
when transmitted from one generation to the next, and
the CCTG portion of the repeat tract is interrupted, most
commonly by both GCTG and TCTG motifs—that is,
(TG)n(TCTG)n(CCTG)nGCTG CCTG TCTG (CCTG)n
(Liquori et al. 2001). On the expanded alleles that have
been sequenced, an uninterrupted variant of the CCTG
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Table 1
Primer Sequences for Newly Developed STR Markers
Marker Accession Number Forward Primer Sequence (5′r3′) Reverse Primer Sequence (5′r3′)
CL3N105 AY326637 TCA GTC AAG GTT CCA CCA GA GCC AGT CCT CAT AGC CAC AT
CL3N122 AY326638 TGC TCC ACA TCC TAA CAC CA TGG GCA AAG GAC CTA AAA AG
CL3N97 AY326639 AGG CAG GAG AAT CGT TTG AA CAG TCT CCC GAA TAG CTG GA
CL3N84 AY326640 TCA TTC CCA GAC GTC CTT TC AAT CGC TTG AAC CTG GAA GA
CL3N99 AY326641 CTG CCG GTG GGT TTT AAG T TGC AAG ACG GTT TGA AGA GA
CL3N94 AY326642 TCA GCT GTG TTC ATG CCA TT AGA GGG AGT GGG TTT GGT TT
CL3N83 AY326643 GTG TGT AAG GGG GAG ACT GG AAG CCC AAG TGG CAT TCT TA
CL3N95 AY326644 CTG GTC TCG AAC TCC TGA GC TCT TCT CTA GTT GGC TAT TTC ATT CA
CL3N96 AY326645 CCC ATT CTC TCC CTC TGT CA TAC CAT GGC TCC CAG AGT TC
CL3N59 AY326646 GCT GGC ACC TTT TAC AGG AA ATT TGC CAC ATC TTC CCA TC
CL3N58D AF388525 GCC TAG GGG ACA AAG TGA GA GGC CTT ATA ACC ATG CAA ATG
CL3N114B AY326647 TTA ATT GAT TCA AGG ACA TTT GTA GTC T AAA AAT TAG CTA AGC GTG GTG ACA G
CL3N116 AY326648 AGA TGG GCA AAT GGA AAG TG GGG CGA GAC TCT GTC TCA AA
CL3N117 AY326649 TCA TCC CAA ACT GAA TCC TCA CTG GTG ATG CCT TGG AAA AT
CL3N118 AY326650 TCA CAT GCA TTG CCT ACC AT CAC AGA AAA CTG CAC CCA GA
CL3N119 AY326651 CAA GCA AAT GTT CCC TGA CA AGG GTC AGA CAG AGC TGG AA
CL3N121 AY326652 AGC CAC TTC ACT CCA GCC TA GTA CAG CAG GGC CTT GTA GC
CL3N19 AY326653 GAC AGG CCA AAG TGT GTG TG GGC AAA AAT AAA GCC ACA GC
CL3N23 AY326654 GCC CTT CCC AAC TAT GTA GC CCA GTC TGG GTG ACA AAG TG
portion of the repeat tract is elongated (Liquori et al.
2001). For several diseases, the loss of sequence interrup-
tions is thought to predispose normal alleles to expansion
(Chung et al. 1993; Kunst and Warren 1994; Gunter et
al. 1998). Expanded DM2 alleles show unprecedented
somatic instability, with signiﬁcant increases in length
over time (e.g., 2,000 bp/3 years) and expanded alleles
often appearing as smears by Southern analysis (Liquori
et al. 2001; Day et al. 2003).
Linkage disequilibrium played an important role in
the identiﬁcation of the DM2 mutation (Liquori et al.
2001). Several markers within the DM2 critical region
were in linkage disequilibrium with the mutation, as
shown by transmission/disequilibrium test analysis, in-
cluding CL3N58 ( ), CL3N59 ( ),P ! .000001 Pp .0001
CL3N84 ( ), and CL3N99 ( )Pp .0001 Pp .0075
(Liquori et al. 2001). These data suggested the possibility
that the DM2 expansions may have originated from one
or more founder mutations. This would be consistent
with DM1, in which expanded CTG alleles in individuals
of European ancestry are thought to have arisen from
a single 30-kb haplotype that includes nine polymorphic
markers (Imbert et al. 1993; Neville et al. 1994; Chak-
raborty et al. 1996). Several extragenic polymorphisms
can extend this associated haplotype up to 160 kb from
the expansion, although these polymorphisms are not in
complete linkage disequilibrium with expanded alleles.
To further investigate the ancestral origin(s) of the
DM2 expansion, we have performed haplotype analyses
of 71 families with DM2. In addition, the possibility that
the normal repeat tract found in humans has a conserved
biological function was investigated by studying the evo-
lutionary conservation of the repeat tract and ﬂanking
intron sequence in chimpanzee, gorilla, mouse, and rat.
Materials and Methods
Families with DM2
We identiﬁed, obtained informed consent from, per-
formed neurological exams of, and collected blood
samples from family members of patients with DM2/
PROMM. The study was performed on 71 families,
consisting of 301 individuals, including affected patients
( ) and their unaffected relatives. All of the fami-np 210
lies with DM2 that we have identiﬁed are white (i.e.,
persons of European, North African, or Southwest Asian
descent), with 70 families of Northern European descent
and 1 from Afghanistan. Genomic DNA was isolated
from blood with the Puregene kit D-5000 (Gentra Sys-
tems). For evolutionary conservation studies, genomic
DNA from three common chimpanzees (Pan troglodytes)
and two gorillas (Gorilla gorilla) was isolated from ve-
nous blood of animals at the Como Zoo (St. Paul, MN),
and DNA from mouse (FVB/N) was isolated from tail
snips with the Puregene kit D-5000 (Gentra Systems).
Genetic Conﬁrmation of Families with DM2
Affected individuals were determined to beDM2-posi-
tive by one or more of the following: (i) PCR, by use of
the primers CL3N58D F and CL3N58D R, published
elsewhere (GenBank accession number AF388525),
which resulted in a blank allele pattern, as described else-
where (Liquori et al. 2001); (ii) Southern blot analysis,
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Figure 1 Map of newly developed polymorphic markers in DM2 region. We generated a series of novel polymorphic genetic markers
containing STRs and SNPs. The markers and relative map positions are indicated with the distance in kilobases from the CCTG repeat given
below the marker. The seven SNPs located between markers CL3N59 and CL3N58 are indicated below the solid bar. Nine BACs, spanning
12 Mb, are shown (dark gray horizontal boxes).
which resulted in detection of an expanded allele (Liquori
et al. 2001; Day et al. 2003); and (iii) repeat assay test,
performed as described elsewhere (Day et al. 2003).
Development of STR Markers in the DM2 Region
Additional polymorphicmarkerswere developedbyde-
signing PCR primers that ﬂank STR sequences identiﬁed
by analysis of available sequence information from the
UCSCGenome Browser andNational Center for Biotech-
nology Information (NCBI) databases. PCR primers and
allele frequencies are shown in tables 1 and 2, respectively.
Allele frequencies were calculated for each marker by use
of the alleles from spouses in all families analyzed. When
sufﬁcient data were available, control haplotypes were
determined for these same individuals. Marker positions
relative to ZNF9 and the DM2 expansion are based
on sequence information from UCSC and NCBI (ﬁg. 1).
Haplotype Analysis
PCRs for all markers were done with a 5-ml reaction
(200 mM deoxynucleotide triphosphates [dNTPs], 10
mM tris-HCl [pH 9.0], 50 mM KCl, 0.1% Triton X-100,
0.01% [weight/volume] gelatin, 1/1.5/2 mM MgCl2, 0.4
mM each primer, 0.1 U Taq) cycled 35 times (94C for
45 s, 51C/54C/57C for 45 s, and 72C for 60 s). For
each reaction, the forward (F) primer was end labeled
with 33gP adenosine triphosphatewithT4polynucleotide
kinase (Epicentre). PCR products were run on 4% acryla-
mide (8M urea) gel at 65 watts.
Affected haplotypes were established by determining
which allele cosegregated with the disease in each family.
Control haplotypes were constructed by determining the
alleles that were passed from parents to their offspring.
In the event that the associated allele for a marker could
not be unequivocally determined, both alleles are given
(ﬁg. 2 [top]).
Haplotypes are given in the order CL3N105-
CL3N122-CL3N97-CL3N84-CL3N99-CL3N94-
CL3N83-CL3N95-CL3N96-CL3N59-CL3N58 (DM2-
EXP)-CL3N114-CL3N116-CL3N117-CL3N118-
CL3N119-CL3N121-CL3N19-CL3N23, with alleles
designated by their size in base pairs and the DM2 ex-
pansion designated by “exp” (ﬁg. 2 [top]).
SNP Analysis
Potential SNPs were identiﬁed on the basis of infor-
mation from the UCSC Genome Browser andNCBI SNP
database. SNPs were analyzed by PCR ampliﬁcation (as
above, except that reactions were performed in 15-ml vol-
Table 2
Allele Frequencies of STR Markers
Marker and Alleles in bpa %
CL3N105 ( ):np 193
240 .5
238 .5
236 1.0
234 4.7
232 13.0
230 15.0
228 20.7
226 17.1
224 16.6
222 10.9
CL3N122 ( ):np 80
219 1.3
215 5.0
213 5.0
211 25.0
209 46.1
207 15.0
205 1.3
203 1.3
CL3N97 ( ):np 128
202 .8
198 11.7
194 19.5
190 65.6
186 .8
182 .8
178 .8
CL3N84 ( ):np 201
157 15.4
155 .5
153 1.5
151 57.8
149 12.4
147 11.9
145 .5
CL3N99 ( ):np 209
191 .5
185 .5
183 1.0
181 1.4
179 2.9
177 6.2
175 15.3
173 5.3
171 18.6
169 18.2
167 6.2
165 16.7
163 1.4
161 1.9
159 1.9
157 1.0
155 .5
149 .5
(continued)
Table 2 (continued)
Marker and Alleles in bp %
CL3N94 ( ):np 202
162 1.5
160 6.9
158 6.4
154 3.0
152 50.0
150 2.0
148 29.2
144 1.0
CL3N83 ( ):np 213
197 1.4
195 .5
193 .9
191 4.7
189 15.5
187 14.6
185 48.7
183 3.3
181 1.9
173 5.2
171 3.3
CL3N95 ( ):np 202
236 1.0
232 .5
228 .5
224 6.9
222 23.8
220 .5
216 1.5
214 13.9
212 35.0
210 1.5
206 13.4
204 1.5
CL3N96 ( ):np 207
163 .5
161 9.2
159 23.7
157 51.1
155 15.5
CL3N59 ( ):np 202
151 .5
149 5.0
147 .5
145 6.4
143 10.9
141 31.7
139 20.3
137 15.3
135 7.9
133 .5
131 1.0
CL3N114 ( ):np 82
297 1.2
292 1.2
291 7.3
(continued)
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Table 2 (continued)
Marker and Alleles in bp %
290 2.4
289 8.5
288 69.6
287 9.8
CL3N116 ( ):np 68
244 2.9
226 1.5
224 4.4
222 89.7
218 1.5
CL3N117 ( ):np 78
241 2.6
239 82.0
237 2.6
235 12.8
CL3N118 ( ):np 74
229 9.5
227 78.3
221 12.2
CL3N119 ( ):np 78
244 1.3
242 1.3
240 1.3
238 1.3
236 3.8
234 11.5
232 28.2
230 35.9
228 3.8
226 10.3
222 1.3
CL3N121 ( ):np 80
231 13.8
227 44.9
223 41.3
CL3N19 ( ):np 72
207 1.4
205 4.2
203 5.6
201 9.7
199 18.1
197 15.3
195 22.0
193 4.2
191 4.2
181 12.5
179 2.8
CL3N23 ( ):np 70
238 7.1
235 1.4
234 8.6
231 1.4
230 12.9
226 24.4
222 27.1
218 5.7
216 1.4
214 8.6
210 1.4
NOTE.—Alleles associated with the affected
haplotype are shown in bold italics.
a n p number of chromosomes analyzed.
umes and without labeling the F primer) of a 400–600-
bp region surrounding the SNP of interest, followed by
restriction enzyme digestion (1 U/sample) for 3 h at ap-
propriate conditions. The digested products were run out
on a 1%–2% agarose gel containing EtBr (1ml/100 ml
gel) at 150 volts.
SNP genotypes are shown in table 3, and PCR primers
and restriction-enzyme information are summarized in
table 4, with NCBI reference sequence numbers given in
parentheses. All restriction enzymes were from New
England Biolabs, except forMaeIII, which is fromRoche
Molecular Biochemicals.
Sequencing of Normal DM2 Alleles
PCR ampliﬁcation and cloning of normal DM2
(CL3N58) alleles was performed as described elsewhere
(Liquori et al. 2001). To simplify the sequencing, PCR
products were preferentially ampliﬁed from affected off-
spring who inherited the normal haplotype of interest,
as only a single allele within the normal range would
be ampliﬁed. For each allele, the PCR and subsequent
sequencing was performed at least twice (ﬁg. 3).
Intron Analysis in Chimpanzee and Gorilla
DNA immediately ﬂanking the DM2 repeat was am-
pliﬁed from the genomic DNA of three chimpanzees and
two gorillas with primers CL3N58D F and CL3N58D
R, as described elsewhere (Liquori et al. 2001). A larger
region of ﬂanking sequence (1.4 kb) was ampliﬁed by
PCR from genomic DNA with primers JJ1 F (5′-CCT
TTG CAC ATC TTC CCA TA-3′), JJ1 R (5′-TGG CAG
TAA TAC TCA TTC ACT CA-3′), JJ3 F (5′-GCT GGA
GTG CAC TGG TAT GA-3′), and JJ3 R (5′-CAG CTA
CTT GGG AGG CTG AG-3′) in a 15-ml reaction, with
an annealing temperature of 54C and 1.0 mM MgCl2.
Alleles ampliﬁed by PCR were cloned with the TOPO
cloning kit (Invitrogen), and at least ﬁve independent
clones were sequenced for each individual. In some cases,
the PCR products were sequenced directly.
Mouse CNBP Intron 1 Sequencing
BACs containing murine homolog of ZNF9 (cellular
nucleic acid binding protein [CNBP]) were identiﬁed from
RPCI-23 mouse BAC high-density membranes (Invitro-
gen). A probe to mouse exon 5 was generated by PCR
with primers mouse E5 F (5′-GGT GAA ACT GGT CAT
GTA GCC-3′) and mouse E5 R (5′-TGG GAA CAG CCT
CTA TCT GC-3′), with an annealing temperature of 54C
and 1.0 mM MgCl2, labeled with
32P and hybridized.
BACs were identiﬁed as described in the Research Ge-
netics protocol. All positive BACs were grouped by ﬁn-
gerprint maps (NCBI Clone Registry); two BACs were
chosen from each group, and each was checked by PCR
with the mouse E5 primers. Two clones containingmouse
Figure 2 Top, Haplotypes of 71 families with DM2. The three major affected haplotypes (A, B, and C) found in 71 families with DM2
analyzed are shown. The consensus haplotype A is indicated in gold. Minor deviations in repeat size are indicated by alternative colors, with
a color key located below the ﬁgure. The markers span 2.2 Mb, and the distance of each marker from the DM2 CCTG expansion is denoted
at the top of ﬁgure. The STR marker name and the repeat motif associated with each are designated. Bottom, Proposed ancestral origin of
DM2 haplotypes. Proposed ancestral relationship between the major haplotype variants is shown, with haplotype B and C related to haplotype
A, by a small number of ancestral recombination and microsatellite instability events.
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Table 3
SNPs Associated with DM2-Affected Haplotypes
Marker Accession Number
Distance from
(CCTG)n
(kb) Haplotypes A/B Haplotype C
Frequency
(%) Number
CL3N59 AY326646 119.1 149 141
SNP2 rs762570 109.5 T T 100 36
SNP4 rs970572 65.1 G G 99.4 160
SNP13 rs2128342 58.0 G G 100 36
SNP3 rs1021123 54.3 T T 100 34
SNP9 rs2062125 29.4 T T 98.9 178
SNP8 rs1482409 14.0 T T 96.4 110
SNP7 rs1351596 10.2 C C 98.8 168
CL3N58 AF388525 0 Expansion Expansion
CNBP—RP23-398k17 and RP23-91i11—were identiﬁed
and grown in 500 ml Luria broth media overnight at
37C, and DNA was prepared using the QIAGEN large
Construct kit (QIAGEN), as described. Sequencing was
performed and sequence alignments were done with
GeneTool Lite, v. 1.0, (Doubletwist) or BLAST.
Results
Haplotype Analysis of 71 Families with DM2
Haplotype analysis was performed on 71 families
with DM2. All affected individuals received a diag-
nosis of DM and tested positive for the DM2 expan-
sion. The families from Germany ( ) and Min-np 60
nesota ( ) are all of European descent, and therenp 10
was one additional family from Afghanistan (denoted
by a triple asterisk [***] in ﬁg. 2 [top]). Nineteen STR
markers were developed and used in the analysis (ta-
ble 1). These markers span a region of 2.2 Mb, now
with complete coverage by BACs (ﬁg. 1). The CL3N58
marker contains the DM2 CCTG repeat tract, which
is expanded in affected individuals.
The majority of families with DM2 share one of three
common haplotypes (A, B, or C), each of which spans
a core region of ∼700 kb between the CL3N122 and
CL3N19 markers. In each case, the haplotypes signiﬁ-
cantly diverge at the ﬂanking markers CL3N105 and
CL3N23 (ﬁg. 2). Of the families with DM2, 21 have
the conserved haplotype A (shown in gold). Thirty-four
families have a second related haplotype (haplotype B),
likely derived from haplotype A by an ancestral recom-
bination event involving the four most distal markers and
microsatellite repeat slippage at CL3N99 and CL3N83.
The large numbers of alleles with differing sizes at the
CL3N99 and CL3N83 markers within both the highly
related A and B haplotype blocks suggest that these mi-
crosatellite markers, (CA)23–36 and (GT)14–28, show higher
rates of mutability than neighboring markers. The third
major DM2 haplotype, designated “haplotype C,”
which is shared by nine families, appears to have had
two recombination events, the ﬁrst between the DM2
repeat tract and the next centromeric marker located
119 kb proximal to the mutation and the second be-
tween the CL3N121 and CL3N19 markers on the telo-
meric side. Our hypothesis that haplotypes B andC arose
from the common consensus haplotype A by several an-
cestral recombination events is shown in ﬁgure 2 [bot-
tom]. Six of the seven additional families (35, 36, 37,
59, 69, and 70) have variations of the major haplotypes
that can be explained by similar recombination and mi-
crosatellite instability events that have occurred in the
ﬂanking regions. It is possible that the haplotype found
in family 71 is related to that found in families 69 and
70 on the distal side of the repeat tract and that the
variation in repeat size for the CL3N114 marker is due
to microsatellite instability. Alternatively, the mutation
in this family could have arisen independently.
DM2 Haplotypes Converge, Suggesting a Single
Founder
Haplotype A shares seven consecutive STR markers
ﬂanking the repeat with haplotype B and six consecutive
STR markers adjacent to the telomeric side of the repeat
tract with haplotype C. On all three haplotypes, markers
CL3N114, CL3N116, CL3N117, andCL3N118 (located
35, 74, 103, and 127 kb telomeric to the repeat tract) are
conserved, suggesting that the haplotypes converge near
the DM2 mutation.
Haplotype convergence, on the basis of the STRmarker
data presented in ﬁgure 2 (top), is consistent with a group
of SNP markers that were typed within 109.5 kb of the
DM2 mutation. Although the SNP haplotype was also
conserved, it was far less informative and, on the basis
of allele frequencies, would be predicted to be found on
94% of chromosomes.
Possible Premutation Allele Found on Control
Chromosome
To determine how common the DM2 expanded allele-
associated haplotypes are in the general population, we
examined the haplotypes of 228 control chromosomes
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Figure 3 A, Identiﬁcation of potential premutation allele in the general population. The consensus between haplotype B and a possible
premutation allele in an unaffected control is depicted. Identical coloring indicates the regions where the haplotypes are shared. The sequence
of the DM2 expansion region in the possible premutation allele is indicated below the haplotype. B, The schematic diagram showing the repeat
conﬁgurations of the DM2 expansion region on 24 normal control alleles, 3 expanded affected alleles, and the putative premutation allele.
from unrelated spouses andCEPH family controls. A total
of 110 distinct haplotypes was observed, spanning eight
markers from CL3N84 to CL3N58 (380 kb). The most
common haplotype found in the general population
( ; 6.6%) was 151-169-152-185-212-157-141-np 15
224, but the majority of haplotypes represented (np
) were unique.72
One control chromosome (0.44%) had a haplotype
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Table 4
Summary of SNP Markers
Marker and Primer Sequence (5′r3′)a Enzyme NTb Cut
Product
(bp)
SNP2 (rs762570):
F: GCC TTC TGA CCT CTC TGG AA Bsu36I C Yes 291, 206
R: AAC ATC TGC ACC TCC AAA CC T No 497
SNP4 (rs970572):
F: CCA AAG TAG CAG GGA ACT GG BstUI A No 495
R: AAA GGT GCA CTG TGG GAA AC G Yes 272, 223
BssSI A Yes 276, 219
G No 495
SNP13(rs2128342):
F: TCA TGA GAA AAG CGA TGG AA RsaI A Yes 285, 118, 59
R: TTG GTT TCT CAG CCT AGT TGC G No 344, 118
SNP3 (rs1021123):
F: ACG GGA AGA GAT GCA AAG GT MaeIII C Yes 314, 173
R: GCT TTC CCT GTG ATT CTT TAC AA T No 487
SNP9 (rs2062125):
F: CAG AGT CTC GCT TCA TCA CC HinP1I C Yes 329, 126
R: TCC GTC GCA AAA ACA AAA AT T No 455
SNP8 (rs1482409):
F: ACC TCA GCC TCC CCA AGT AT SspI C No 502
R: CAG GGG TTG TGA GAG TGA CA T Yes 277, 225
SNP7 (rs1351596):
F: GGA ATG ACC CTG CTT GTT TC Tsp45I C Yes 267, 133, 104
R: CTA GTG ATG GGC ACC CTA GC MaeIII T No 371, 133
a F p forward primer; R p reverse primer.
b NT p nucleotide.
Figure 4 Evolutionary comparisons of the DM2 repeat tract. Schematic diagram of DM2 repeat region shows consensus sequence
conﬁgurations found in human, chimpanzee, gorilla, mouse, and rat.
identical to a 470-kb portion of haplotype B, spanning
the DM2 repeat tract from markers CL3N122 to
CL3N116, with a probable recombination event and
a distinct haplotype beginning ∼103 kb telomeric to
the DM2 repeat tract (ﬁg. 3A). Two others had partial
matches to haplotype B, with minor deviations. Similarly,
one control chromosome (0.44%) had a haplotype iden-
tical to the DM2 haplotype C, spanning the DM2 repeat
from CL3N122 to CL3N116, with similar divergence.
Thirteen other chromosomes had partial matches to hap-
lotype C. To determine if any of these haplotypes could
be related to their DM2 counterparts, we sequenced the
normal DM2 alleles associated with these 17 control hap-
lotypes (ﬁg. 3B).
The CL3N58 alleles on the control haplotypes that
were partial matches to either DM2 haplotype B or C
all had CCTG repeat tracts that resembled other normal
alleles, including the presence of interruptions within the
CCTG portion of the repeat tract. Thirteen control chro-
mosomes with partial matches to haplotype B or C pos-
sess repeat tracts with the conﬁguration (CCTG)5GCTG
CCTG TCTG (CCTG)7. More size variation in both the
TG and TCTG portions of the repeat tracts was observed,
indicating that these two motifs are generally more poly-
morphic than the normally interrupted CCTG portion of
the DM2 repeat tract (ﬁg. 3B).
The CCTG tract on the haplotype identical to DM2
haplotype C was similar to the other control alleles and
also contained an interrupted CCTG repeat with the con-
ﬁguration (CCTG)nGCTG CCTG TCTG (CCTG)n. In
contrast, the CCTG tract on the haplotype identical to
DM2 haplotype B lacked interruptions and is the longest
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Figure 5 Conservation of ZNF9 intron 1 regions. A, PCR strategy and alignment of the human, chimpanzee, and gorilla sequences 550-
bp 5′ and 590-bp 3′ of the DM2 expansion regions. An asterisk (*) indicates that the nucleotides at the position are identical in the
three sequences. Gray shading indicates base pair differences from the human sequence. B, Schematic diagram showing the homology among
the human, mouse, and rat intron 1. Gray shading represents regions of homology among human, mouse, and rat sequences, with percentage
of homology indicated in each region. Dark gray boxes represent the ﬂanking exons, and the gray vertical line represents the repeat tract. C,
Alignment of human, mouse, and rat sequence 200-bp 3′ of the respective repeats. Dark gray shading indicates that the nucleotides at the
position are identical in the three sequences. Medium gray shading indicates nucleotides that are conserved between mouse and rat but differ
from the human. Light gray shading indicates nucleotides that are identical between human and either the mouse or the rat but not both. D,
Summary of regions of intron 1 homology among human, chimpanzee, gorilla, mouse, and rat.
known pure CCTG tract appearing within the normal
population at (CCTG)20 (ﬁg. 3A and 3B). The haplotype
conservation of 11 highly polymorphic STR markers
1470 kb and the fact that this is the only control allele
we have seen with an uninterrupted CCTG repeat sug-
gests that this allele represents a pool of premutation
alleles for DM2, which, because they lack sequence
interruptions, are predisposed to further expansion.
Conservation of the Repeat Tract and Intron 1
We performed PCR on the genomic DNA from chim-
panzee and gorilla using the primers for amplifying the
human DM2 repeat (CL3N58D F and R) (Liquori et al.
2001). Sequencing of the CL3N58D products revealed
that both primates had complex repeat motifs that were
similar but not identical to the human DM2 repeat tract
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(ﬁg. 4). Chimpanzee has a (TG)nTCTG (CCTG)n, with
interruptions in the TG rather than the CCTG tract (ﬁg.
4). Gorilla has a (TG)n(CCTG)nTCTG CCTG (TCTG)n
and a (TCTG)n(CCTG)nTCTG CCTG TCTG, separated
by a 38-nt stretch with homology to an Alu repeat (ﬁg.
4). To determine if homology in the primate ZNF9 in-
trons continues beyond the repeat region, PCRwas done
on two regions ﬂanking the repeat (∼550 and 590 bp),
again with primers designed for the human sequence (JJ1
F and R; JJ3 F and R). Both the 5′ ﬂanking region (chim-
panzee 98.9%; gorilla 98.7%) and the 3′ ﬂanking region
(chimpanzee 98.0%; gorilla 96.8%) are highly conserved
(ﬁg. 5A).
We further investigated conservation of the repeat tract
and intron 1 by comparing the mouse and rat homologs
of the ZNF9 gene, known as “the cellular nucleic acid
binding protein” (CNBP) gene, with the human homo-
log. For mouse, we identiﬁed two BAC clones containing
the homolog of ZNF9 (CNBP) by screening the BAC
high-density membranes by hybridization. Both clones
map to mouse chromosome 6, which is syntenic to the
human DM2 region. Intron 1 of mouse CNBP was se-
quenced from the BAC clones (AY329620).
The sequence of intron 1 from the rat was determined
by comparing rat mRNA sequence (D45254) with the rat
genomic sequence (AC097129) by BLAST analysis. The
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Table 5
Intron 1 Sequence Information
Species Sequence Description Accession Number
Human Complete intron 1 AY329614
Mouse Complete intron 1 AY329615
Rat Complete intron 1 AY329616
Chimp 5′ JJ1 AY329608
Chimp 3′ JJ3 AY329609
Gorilla 5′ JJ1 AY329610
Gorilla 3′ JJ3 AY329611
Chimp 5′r3′ JJ1–JJ3, incl 58 AY329612
Gorilla 5′r3′ JJ1–JJ3, incl 58 AY329613
Human conserved AY329617
Chimp conserved AY329618
Gorilla conserved AY329619
Mouse conserved AY329620
Rat conserved AY329621
size of intron 1 in both the mouse (5.1 kb) and the rat
(5.8 kb) is much smaller than in the human gene (12
kb), with the mouse and rat introns conserved through-
out their length (∼85%) (ﬁg. 5B). In contrast, only a small
region, containing versions of the DM2 repeat tract and
the sequence immediately 3′ of the repeat tract, is shared
among human, mouse, and rat (ﬁg. 5B–5D). The 200-
bp sequence downstream of the conserved repeat tracts
is 51% conserved between human and mouse and 48%
conserved between human and rat (ﬁg. 5D). In mouse,
the repeat tract is composed of two of the three sequence
motifs, (TG)5TCTG TG (TCTG)2, found in humans,
whereas the rat contains only a simple (TG)23 repeat at
the homologous intronic site (ﬁg. 4). Accession numbers
for the newly developed STRmarkers, as well as sequence
information, are summarized in tables 1, 5, and 6.
Discussion
Haplotype analysis of 71 families with DM2 was per-
formed to assess the possible origins of the DM2 expan-
sion. The majority of families analyzed are of German or
European descent, with one family from Afghanistan.
Several general predictions can be made from our data.
All of the families appear to have variations of the con-
sensus haplotype A, in which haplotypes B and C appear
to be derived from haplotype A by a limited number of
ancestral recombination and microsatellite instability
events (ﬁg. 2 [top]). Microsatellite instability is fairly
common at the population level and is the basis for the
high rates of heterozygosity of microsatellite repeat
markers (Weber and Wong 1993). A diagram depicting
how these major haplotype variants could have been
derived from a single common haplotype is presented in
ﬁgure 2 (bottom). Seven additional and slightly variant
DM2 chromosomes, all of which contain a core region
of conservation, appear to be related to the more com-
mon haplotypes by similar recombination and/or mi-
crosatellite instability events. Similar to DM1, haplotype
conservation in the families we have studied suggests
that DM2 arose from a single, or perhaps a few, common
founders, at least in patients of European and Afghan
ancestry.
The affected DM2 haplotype in the native Afghan
family (Tajiks fromKabul) is strikingly similar to the core
region of the consensus haplotype, with seven markers
shared over a 456-kb interval. Although estimates of hap-
lotype age are difﬁcult because rare ancestral recombina-
tion events are unlikely to be evenly distributed from
generation to generation and because microsatellite mu-
tation rates vary frommarker tomarker, the conservation
of haplotype A in the Afghan family allows us to specu-
late that DM2 was introduced into the Afghan gene pool
sometime between 2000 and 1000 B.C., when the ancient
Aryan tribes of Indo-European extraction settled Aryana
(ancient Afghanistan).
Our linkage disequilibrium (Liquori et al. 2001) and
haplotype data suggest that DM2, like DM1, arose from
a common founder chromosome. For DM1, haplotype
analysis of control chromosomes has suggested that the
DM1 expansion arose through a series of small stepwise
expansions that occurred on chromosomes with a single
haplotype in the general population and that the longer
repeat tracts, which were generally stable within single
families, served as a pool of premutation alleles and a
reservoir of new mutations. In SCA1, SCA2, and FMR1,
the presence of interruptions within the normal CAG and
CCG repeats are thought to confer stability on thenormal
repeat (Chung et al. 1993; Kunst and Warren 1994;
Pulst et al. 1996; Gunter et al. 1998), with the loss of
these interruptions leading to increased instability and
further expansions. Sequence interruptions of the DM2
CCTG repeat tract may serve a similar purpose andmay
confer stability on the CCTG tract, with the loss of
interruptions predisposing the allele to further expan-
sions that could eventually expand into the pathogenic
range.
Although our analysis of 228 control chromosomes
indicates that perfect matches to the major affected hap-
lotypes are relatively rare, we identiﬁed a single control
chromosome with a haplotype identical to a large por-
tion of haplotype B spanning the DM2 repeat tract from
markers CL3N122 to CL3N116. This chromosome,
schematically represented in ﬁgure 3A, has an unusual
uninterrupted (CCTG)20 repeat tract. Within the normal
population, the largest CCTG tract we have observed
contains 26 repeats with two interruptions and the
overall repeat motif (CCTG)12GCTG CCTG TCTG
(CCTG)11. The fact that the (CCTG)20 repeat motif has
a signiﬁcantly longer stretch of uninterrupted repeats
than have been observed on other control alleles and is
found on a haplotype identical to the haplotype B in a
470-kb region ﬂanking the repeat suggests that this nor-
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Table 6
Complete Genomic Sequence
Species Accession Number
Human AY329622
Mouse AY329623
Rat AY329624
mal allele may represent an allele that is less stable than
interrupted alleles in the general population and could
eventually be predisposed to further pathogenic expan-
sion. Follow-up studies to determine if uninterrupted
alleles are commonly found on control chromosomes
with the DM2 haplotype would further support this
initial observation.
Linkage disequilibrium with the DM2 mutation was
apparent only through the use of STRmarkers. Although
seven putative SNP markers were identiﬁed from the
NCBI database, none were useful in distinguishing the
DM2 haplotypes from haplotypes of the general popu-
lation, even though they were located extremely close to
the mutation (10.2–109.5 kb). All of the SNP alleles as-
sociated with the affected DM2 haplotype have fre-
quencies 196% (minor allele frequency !4%) (table 3).
A useful threshold for using SNPs in haplotype analysis
is generally considered to be a minor allele frequency
120%; thus, none of the SNPs in the region were con-
sidered optimal.
Each of the four nonhuman mammals we examined
contained repeats that were similar but not identical to
the human DM2 repeat. The TG portion of the repeat
tract is found in human, chimpanzee, gorilla, mouse, and
rat. In contrast to the human repeat, in the chimpanzee,
the TG tract is interrupted by one or two TT motifs. The
TCTG portion of the repeat tract is found in human,
chimpanzee, gorilla, and mouse, although chimpanzee
has only a single TCTG. The CCTG portion is found in
human, chimpanzee, and gorilla. The least-conserved
CCTG portion of the repeat tract is interrupted in normal
human and gorilla (although the interruptions in gorilla
are more complicated) and is uninterrupted in chimpan-
zee. A 200-bp sequence just 3′ of the respective repeats
is conserved among human, chimpanzee, gorilla, mouse,
and rat. The evolutionary conservation of the repeat and
3′ ﬂanking sequence suggests a biological function. Be-
cause both TG dinucleotide and UCAY tetranucleotide
repeats have been shown to be involved in the regulation
of alternative splicing (Jensen et al. 2000; Gabellini
2001), it is possible that the conserved sequence inZNF9
intron 1 regulates splicing or some other aspect of gene
regulation.
In humans, the a-ZNF9 isoform encodes a 177–amino
acid protein, whereas b-ZNF9 encodes a 170–amino acid
protein lacking the last 7 amino acids of the ﬁrst zinc
ﬁnger motif. Both donor sites at the 3′ end of exon 2
have the same consensus sequence, and both seem to be
recognized with a similar frequency (Flink andMorkin
1995). Although ZNF9 is alternatively spliced and both
TG and UCAY repeats have been shown to be involved
in the regulation of alternative splicing, it seems unlikely
that the normal role of the repeat tract in intron 1,
placed well before the splicing branch site, would have
a role in regulating alternative use of the splice donor
site in exon 2. The fact that the TG portion of the repeat
tract is the most highly conserved suggests that the TG
sequence may provide the most important clues about
the normal function of the repeat tract and the reasons
for its conservation from human to mouse. Substantial
conservation of noncoding sequences throughout the
mouse and human genomes (Mural et al. 2002) suggests
that we have much to learn about the normal function
of noncoding DNA.
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